|
|
Advertisement |
 |
|
|
Advertisement |
 |
Deloitte's 2018 Life Sciences Accounting & Financial Reporting Update
How can life sciences companies keep pace with emerging accounting and financial reporting challenges? Learn about new accounting standards for revenue recognition, leases, and definition of a business and existing rules for R&D, acquisitions and divestitures, income taxes and more. Our ninth annual report also includes interpretive guidance to help you address these challenges.
Download now
|
|
Advertisement |
Do you know an Emerging Pharma Leader?
Nominate a colleague with impressive leadership and career intentions — even yourself! — for Pharmaceutical Executive's 2018 Emerging Pharma Leaders Awards.
Submit your nomination today!
|
|
|
|
/ June 19–20: Rare Disease Innovation Summit
/ |
Boston, MA |
/ June 21–22: Disruptive Downstream Technologies / |
San Diego, CA |
/ August 14–15: Publication Planning 2018 / |
Philadelphia, PA |
/ August 15–16: Reimbursement and Access 2018 / |
Philadelphia, PA |
/ August 20–22: Transparency and Aggregate Spend 2018 / |
Washington, DA, PA |
/ October 15–17: 28th Annual Sharing Conference: Compliance / |
National Harbor, MD |
/ November 13–14: Commercial Data Insights 2018 / |
Philadelphia, PA |
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures / |
Philadelphia, PA |
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences
/ |
London, UK |
/ November 28–29: Compliant Patient Support Programs Summit / |
Chicago, IL |
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
Philadelphia, PA |
/ December 5–6: Bio/Pharma Compliance Congress on Non-Promotional Activities / |
Philadelphia, PA |
|
|
|
Advertisement |
 |
|
|
Advertisement |
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
|
|
Advertisement |
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
|
|
Advertisement |
Combination Therapies in Oncology: The Benefits of Integrated Insights
Thursday, June 14, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now
|
|
|
Industry update |
//
Collegium Pharmaceutical (Canton, MA) announced that Joseph Ciaffoni, Executive Vice President and Chief Operating Officer, will be promoted to Chief Executive Officer and join the Board of Directors effective July 1, 2018. Mr. Ciaffoni will succeed Michael T. Heffernan, who founded Collegium in 2003 and will step down as CEO on June 30, 2018. Mr. Heffernan will continue to serve as Chairman of the Board.
//
Codiak BioSciences (Cambridge, MA) appointed Richard Brudnick as Chief Business Officer and Head of Strategy.
//
Acea Therapeutics (Cambridge, MA), an affiliate of Ionis Pharmaceuticals, announced the appointment of Richard (Rich) A. Moscicki, M.D., to the company's Board of Directors.
//
Strategic Consulting (Baltimore, MD) announced that the firm's Managing Director, Robert Ferguson, will assume the position of President of the firm. Ferguson will assume all aspects of management and direction of the business from Thomas Weschler, who founded the company in 1996.
//
TG Therapeutics (New York, NY) appointed Adam Waldman as Chief Commercial Officer.
//
Hikma Pharmaceuticals (London, UK) appointed Henriette Nielsen to the newly created role of Chief Transformation Officer.
//
Ali Mortazavi stepped down as Chief Executive Officer and as a Director of the Silence Therapeutics (London, UK) after six years. Company Chair Dr. Annalisa Jenkins has assumed the role of Executive Chair in an interim capacity.
//
|
|
|
Advertisement |
Patient Engagement in Clinical Trials
On Demand
Learn more
|
|
Advertisement |
Capturing The Attention of Investors: How to create a compelling value story
On Demand
Learn more
|
|
|
|